Creating Hope Reauthorization Act of 2024
Do you support it?
Want to know if it passes?
We'll email you when HR 7384 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 7384.
You're tracking HR 7384
We'll email you the moment it moves.
HR 7384 — Creating Hope Reauthorization Act of 2024
Last action — Referred to the Subcommittee on Health.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill died with 118th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
Bill Text
- Introduced Introduced in House Current html February 15, 2024
Compared against current U.S. Code AI-generated reading aid — verify against the official bill.
The bill extends the expiration dates for priority review vouchers related to treatments for rare pediatric diseases.
-
21 U.S.C. 360ff(b)(5)
September 30, 2024→ September 30, 2028Changes the expiration date for issuing priority review vouchers from 2024 to 2028.
-
21 U.S.C. 360ff(b)(5)(B)
September 30, 2026→ September 30, 2030Changes the expiration date for an additional issuance related to pediatric diseases from 2026 to 2030.
Action History
-
Referred to the Subcommittee on Health.
-
Introduced in House
-
Introduced in House
-
Referred to the House Committee on Energy and Commerce.
Sponsors
- Michael T. McCaul · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
- McCaul, Michael T. Republican
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 7384 do?
- To amend the Federal Food, Drug, and Cosmetic Act to extend the authority of the Secretary of Health and Human Services to issue priority review vouchers to encourage treatments for rare pediatric diseases.
- Who sponsors HR 7384?
- HR 7384 is sponsored by McCaul, Michael T. (Republican).
- What is the current status of HR 7384?
- This bill died with 118th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 7384?
- Track HR 7384 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 7384
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 7384
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →